SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

6827 (6827) News

Follow 6827 (6827) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 6827 Asset market Sector Markets 90 days 1 Updated Sep 09, 2026, 08:06 AM UTC Open live news feed
M MegaPro Biomedical submits FDA application for Phase III MPB-1523 trial MegaPro Biomedical Co Ltd has submitted an application to the FDA to conduct a Phase III trial on MPB-1523. REGULATION | Sep 09, 2026, 08:06 AM UTC